Examoto is dedicated to the design, deployment, and operation of Risk Evaluation and Mitigation Strategy (REMS) services in the pharmaceutical market
UBC (Blue Bell, PA), a company providing integrated clinical, safety, and commercialization services for the biopharma industry, has announced that it has acquired Examoto, LLC, a Risk Evaluation and Mitigation Strategy (REMS) firm.
Examoto founder Jason Leedy commented, “Examoto’s technology and design innovations, in concert with UBC’s Project Management Office and related REMS services, creates a REMS powerhouse. We will collectively have the most comprehensive, proven capabilities for risk mitigation solutions for the pharma industry.”
Natalie O’Donnell, corporate vice president, UBC Safety and Risk Management, added, “Our acquisition of Examoto helps cement UBC’s status as a preeminent leader in this category, with a full-service REMS solution that leverages enhanced technologies and product innovations to help mitigate safety risk while optimizing the commercialization and delivery of products to market.”
Trending Data & Response Plans in the Cleanroom Setting
April 30th 2025Being proactive with and responsive to your environmental monitoring (EM) data helps prevent problems with cleanroom contamination. Learn more about EM and cleanroom best practices and to see how ABM can implement industry-leading cleanroom solutions for your facility.
ABM’s Digital Solution for Good Manufacturing Practices
April 30th 2025Learn how our digital GMP solution ensures compliance with high regulatory standards, and offers faster, more accurate data access. By utilizing a mobile app for data collection and a management dashboard for task visibility and validation, it goes beyond traditional paper methods to meet growing industry needs.